Early-stage Trial to Determine a Safe and Effective Dose for Ratutrelvir in Patients With Mild to Moderate COVID-19
Trial details
- Registry ID
- NCT07157007
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Early-stage Trial to Determine a Safe and Effective Dose for Ratutrelvir in Patients With Mild to Moderate COVID-19NCT07157007 | TRAW | Phase 2 | Completed | 2026-02-16Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |